Bringing the very best science and medicine to our best equine friends
Events

KindredBio Announces Pricing of Public Offering

SAN FRANCISCO, July 12, 2017 /PRNewswire/ — Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced the pricing of an underwritten public offering of 3,000,000 shares of its common stock at a public offering price of $7.50 per share, for a total offering amount of $22.5 million before deducting underwriting discounts and commissions and estimated offering expenses payable by KindredBio. KindredBio has granted to the underwriters a 30-day option to purchase up to an additional 450,000 shares of its common stock. All of the shares are being offered by KindredBio. …

Continue Reading

KindredBio Announces Proposed Public Offering of Common Stock

SAN FRANCISCO, California. (July 11, 2017) – Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced a proposed public offering of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc., is acting as sole book-running manager and Aegis Capital Corp. is acting as the lead manager. KindredBio intends …

Continue Reading

Kindred Biosciences Announces Acquisition of Kansas Manufacturing Plant and Execution of Commercial Manufacturing Agreement for Zimeta

Company to Hold Conference Call and Webcast at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time on Monday, June 26, 2017 San Francisco, CA (June 26, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that it has acquired a manufacturing facility in Elwood, Kansas. The purchase of this property, formerly owned by Boehringer Ingelheim and by Strategic Veterinary Pharmaceuticals, Inc., includes approximately 8 acres of land and two buildings encompassing approximately 180,000 square feet with clean rooms, utility, equipment, and related quality documentation suitable for small molecule …

Continue Reading

Kindred Biosciences to Present at 7th Annual LD Micro Invitational

San Francisco, CA (May 24, 2017) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced that Denise Bevers, Co-Founder and COO, will be presenting and hosting one-on-one investor meetings at the 7thAnnual LD Micro Invitational in Los Angeles, CA on Tuesday, June 6, 2017 at 1:30 PM PST. The conference will be held at the Luxe Sunset Bel Air Hotel. Following the presentation, the slide deck will be available for 30 days on the Company’s website: https://kindredbio.com/investor-relations/events. About Kindred Biosciences Kindred Biosciences is a development-stage biopharmaceutical company focused on saving and …

Continue Reading

Kindred Biosciences Receives Approval of Effectiveness Technical Section from FDA for Zimeta New Animal Drug Application

San Francisco, CA (October 4, 2016) Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced it has received a technical section complete letter for effectiveness from the U.S. Food and Drug Administration’s Center for Veterinary Medicine for Zimeta™ (dipyrone injection) approving the technical section. The basis for this complete letter was a multicenter, randomized, blinded, placebo-controlled pivotal study that enrolled 138 horses to assess the effectiveness of Zimeta. The primary endpoint was improvement (a 2°F or greater decrease in temperature from baseline) or resolution of fever (a return to normothermia …

Continue Reading

QH Kids in STEM Sign-Up Opens

QH Kids in STEM Sign-Up Opens Sponsored by Kindred Biosciences to encourage youth from quarter horse backgrounds to study and pursue careers in science, technology, engineering and mathematics. Indianola, IA: The GoodRide Group STEM Alliance and Kindred Biosciences (NASDAQ: KIN) are excited to announce that youth and parents from around the country can sign up to participate at no cost in QH Kids in STEM. “Inspire and engage is the goal for QH Kids in STEM digital series as the demand for skilled workers in science, technology, engineering and mathematics continues to rise,” cited Kris Moorman, founder of The GoodRide …

Continue Reading

Kindred Biosciences Corporate Update via Webcast in Advance of One-on-One Investor Meetings in San Francisco January 12-14, 2016.

Monday, January 11, 2016 Time of Event: 8:30 AM Eastern Standard Time Webcast URL: http://edge.media-server.com/m/p/sfos7gz9  For more information on this event, please see the press release

Continue Reading